Epidemiology — MCQs

An investigator is studying a new biomarker test to detect breast cancer at early stages. A randomized study is conducted to compare the new test to the current standard of care, mammography, among women over 50 years old. They conclude that breast cancer patients whose cancer was identified by the biomarker lived on average 1.5 years longer than those whose cancers were identified by mammography. If additional independent studies show that there truly was no difference in survival between the two groups, which of the following biases is most likely to have occurred?

Q1818

Cyclic trends are seen in which of the following?

Q1819

In epidemiology, generation time is defined as:

Q1820

Demographic gap refers to:

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 1811: Which of the following is not an indicator for malaria surveillance in a population?

A. Annual parasite index
B. Hemoglobin level (Correct Answer)
C. Annual parasite incidence
D. Annual falciparum incidence

Explanation: ***Hemoglobin level*** - While **anemia** (low hemoglobin) is a common complication and clinical consequence of malaria infection, **hemoglobin level is NOT a direct indicator used for malaria surveillance** in a population. - Anemia has multiple etiologies including nutritional deficiencies (iron, folate, B12), chronic diseases, hemoglobinopathies, and other infections - making it a non-specific parameter. - Malaria surveillance requires **specific indicators** that directly measure malaria transmission and disease burden, not secondary clinical consequences. *Incorrect: Annual Parasite Index (API)* - **Annual Parasite Index (API)** is a key malaria surveillance indicator that measures the number of **confirmed malaria cases per 1,000 population per year**. - API is calculated as: (Total positive blood smears / Total population) × 1,000 - API < 1 per 1,000 population is a benchmark target for malaria elimination programs. - Note: API is also called "Annual Parasite Incidence" - these terms are synonymous in current usage. *Incorrect: Annual Parasite Incidence* - **Annual Parasite Incidence** is the same indicator as Annual Parasite Index (API) - the terminology has evolved but both refer to confirmed malaria cases per 1,000 population per year. - This is the **most important single indicator** for monitoring malaria burden and evaluating control program effectiveness. - Used by WHO and National Vector Borne Disease Control Programme (NVBDCP) for malaria surveillance. *Incorrect: Annual Falciparum Incidence (AFI)* - **Annual Falciparum Incidence (AFI)** specifically measures the incidence of ***Plasmodium falciparum*** malaria cases per 1,000 population per year. - This is a critical surveillance indicator because P. falciparum causes the most severe disease with highest mortality. - AFI helps target interventions against the most dangerous malaria species and track progress in reducing malaria-related deaths. - Calculated as: (Total P. falciparum positive cases / Total population) × 1,000

Question 1812: Which of the following factors can lead to an increase in the prevalence of a chronic disease in a population?

A. Immigration of healthy persons
B. Increased cure rate of disease
C. Longer duration of illness (Correct Answer)
D. Decrease in population

Explanation: ***Longer duration of illness*** - Prevalence is determined by the formula: **Prevalence = Incidence × Duration** - A longer duration of illness means individuals live longer with the disease, increasing the pool of existing cases at any given time - Even if incidence remains constant, increased duration (due to improved survival or slower disease progression) directly increases prevalence *Immigration of healthy persons* - Immigration of healthy individuals increases the denominator (total population) without increasing the numerator (disease cases) - This dilutes the proportion of diseased individuals, thereby **decreasing prevalence** *Increased cure rate of disease* - Higher cure rates remove individuals from the pool of existing cases more rapidly - This shortens the effective duration of disease in the population, thereby **decreasing prevalence** *Decrease in population* - A general population decrease would only increase prevalence if healthy individuals selectively left or died at higher rates than diseased individuals - In most scenarios, population decrease affects both groups proportionally and does not predictably increase prevalence - This is not a recognized factor for increasing prevalence in epidemiological principles

Question 1813: Which of the following is false about longitudinal studies?

A. Easy to organize and less time consuming (Correct Answer)
B. Helps us study natural history of a disease
C. Helps in identification of risk factors of a disease
D. Helps us find out rate of occurrence of new cases of a disease

Explanation: ***Easy to organize and less time consuming*** - Longitudinal studies involve **following subjects over a long period**, often many years, making them inherently time-consuming. - They also require **significant resources** for participant recruitment, retention, and data collection, making them complex to organize. *Helps us study natural history of a disease* - Longitudinal studies track individuals over time, allowing researchers to observe the **progression of a disease** from its onset through various stages. - This design is crucial for understanding how diseases develop and change without intervention. *Helps in identification of risk factors of a disease* - By following individuals before disease onset, longitudinal studies can identify **exposures or characteristics** that precede and predict the development of a disease. - This allows for the establishment of **temporal relationships** between risk factors and outcomes. *Helps us find out rate of occurrence of new cases of a disease* - Longitudinal studies are essential for calculating **incidence rates**, which measure the rate at which new cases of a disease occur in a population at risk over a specified period. - They involve following a population free of the disease initially and then observing who develops the disease.

Question 1814: In the context of a cohort study, which of the following statistical measures is not typically used?

A. Incidence rate
B. Attributable risk percentage
C. Relative risk
D. Odds ratio (Correct Answer)

Explanation: ***Odds ratio*** - The **odds ratio** is primarily used in **case-control studies** to estimate the association between exposure and outcome. - While it can be calculated in a cohort study, it is not the most appropriate or typical measure of association, as the **relative risk** can be directly calculated. *Incidence rate* - **Incidence rate** is a measure reflecting the **rate at which new cases** of a disease or health condition occur in a population at risk over a specified period. - It is a fundamental measure in cohort studies to quantify the **risk of developing an outcome** in exposed versus unexposed groups. *Attributable risk percentage* - The **attributable risk percentage** quantifies the proportion of disease in the exposed group that is **attributable to the exposure**. - This measure helps determine the public health impact of an exposure in a cohort study. *Relative risk* - The **relative risk** (also called risk ratio) directly compares the incidence of disease in the exposed group to the incidence in the unexposed group. - It is the **primary measure of association** calculated in cohort studies, indicating how many times more likely an exposed group is to develop the outcome compared to an unexposed group.

Question 1815: Smallpox eradication was declared by WHO in 1980. All of the following epidemiological factors had a role in the eradication of smallpox, except:

A. Life-long immunity
B. Vaccine was highly effective
C. Low rate of asymptomatic transmission
D. Cross-immunity from other animal poxviruses (Correct Answer)

Explanation: ***Cross-immunity from other animal poxviruses*** - This was **NOT** a factor in smallpox eradication and is the correct answer to this "except" question. - The *Variola virus* (which causes smallpox) infected **only humans** - there was no significant animal reservoir. - **No cross-immunity** existed from other animal poxviruses that would have contributed to population-level immunity. - The **absence of zoonotic transmission** (animal-to-human spread) actually *helped* eradication efforts, as eliminating the virus from the human population meant complete eradication. *Low rate of asymptomatic transmission* - The **highly symptomatic nature** of smallpox meant that infected individuals were easily identifiable, allowing for targeted isolation and vaccination. - This limited the spread of the virus by **undetected carriers**, which is a significant challenge for diseases with high rates of asymptomatic spread. - Visible pustular rash made **case detection** straightforward for surveillance programs. *Vaccine was highly effective* - The **vaccinia virus vaccine** provided robust and long-lasting protection against smallpox with a single dose. - Its effectiveness in preventing disease and transmission was central to the success of **ring vaccination strategies** and mass immunization campaigns. - High vaccine efficacy (>95%) meant that vaccination efforts could break transmission chains effectively. *Life-long immunity* - Both natural infection and successful vaccination conferred **long-lasting, often life-long, immunity** to smallpox. - This meant that vaccinated individuals or those who had recovered from the disease did not remain susceptible, preventing **reinfection** and reducing the pool of susceptible hosts over time. - Durable immunity eliminated the need for repeated vaccination campaigns in already-protected populations.

Question 1816: Which of the following is a type of observational study that analyzes population-level data?

A. Ecological study (Correct Answer)
B. Case-control study
C. Randomized controlled trial
D. Longitudinal study

Explanation: ***Ecological study*** - This type of study examines the relationship between an exposure and an outcome at the **population level** rather than the individual level. - It often uses aggregated data, such as incidence rates of disease in different geographic areas, to identify associations. *Case-control study* - This is an **individual-level observational study** that compares individuals with a disease (cases) to individuals without the disease (controls) and looks back retrospectively at their exposures. - It is used to investigate potential risk factors for a disease but does not analyze population-level data directly. *Randomized controlled trial* - This is an **experimental study design** where participants are randomly assigned to an intervention group or a control group. - It is considered the gold standard for establishing causality but does not analyze observational population-level data. *Longitudinal study* - This is an **individual-level observational study** that follows the same group of individuals over a period of time, collecting data at multiple points. - While it observes changes over time, it typically focuses on individual-level trends and outcomes, not aggregated population data.

Question 1817: An investigator is studying a new biomarker test to detect breast cancer at early stages. A randomized study is conducted to compare the new test to the current standard of care, mammography, among women over 50 years old. They conclude that breast cancer patients whose cancer was identified by the biomarker lived on average 1.5 years longer than those whose cancers were identified by mammography. If additional independent studies show that there truly was no difference in survival between the two groups, which of the following biases is most likely to have occurred?

A. Confounding bias
B. Test insensitivity
C. Lead time bias (Correct Answer)
D. Measurement error

Explanation: ***Lead time bias*** - **Lead time bias** occurs when early detection of a disease, such as through a new biomarker, makes it *appear* that survival has increased, even if the actual disease course or prognosis is unchanged. The patient is simply known to have the disease for a longer period. - In this scenario, the biomarker detects cancer **1.5 years earlier** than mammography. This earlier detection artificially inflates the survival time by 1.5 years (from diagnosis to death), even though both groups die at the same chronological age. The apparent survival benefit is simply due to earlier diagnosis, not improved treatment outcomes. - **Key concept**: If a patient would die at age 70 regardless of when cancer is detected, detecting it at age 65 (biomarker) vs age 68.5 (mammography) creates an apparent 3.5-year vs 2-year survival, despite no actual life extension. *Confounding bias* - **Confounding bias** arises when an unmeasured or uncontrolled factor is associated with both the exposure (biomarker use) and the outcome (survival), distorting the perceived relationship. - While confounding can occur in studies, the described phenomenon (earlier detection appearing to extend survival without changing the disease course) is specifically characteristic of lead time bias, not confounding itself. *Test insensitivity* - **Test insensitivity** refers to a screening test's inability to correctly identify individuals who have a particular disease (i.e., a high false-negative rate or low sensitivity). - This bias would lead to *missing* cases, not to an apparent increase in survival for the cases that *are* detected. *Measurement error* - **Measurement error** involves inaccuracies in the data collection process, such as incorrect recording of survival times or faulty test results. - While measurement errors can affect study outcomes, the systematic difference in apparent survival due to earlier diagnosis without actual prognostic improvement is specifically attributed to lead time bias, not general measurement inaccuracies.

Question 1818: Cyclic trends are seen in which of the following?

A. Rabies
B. Measles (Correct Answer)
C. Cholera
D. Hepatitis B

Explanation: ***Correct Option: Measles*** - **Measles** is the classic example of a disease exhibiting **cyclic trends** with epidemic peaks occurring every **2-3 years** - This cyclical pattern results from the **accumulation of susceptible individuals** in the population (primarily newborns and unvaccinated children) until a critical threshold is reached - Influenced by **vaccination coverage**, birth rates, and **herd immunity dynamics** - Between epidemics, the number of susceptibles builds up, leading to periodic outbreaks when immunity in the population wanes below the threshold *Incorrect Option: Rabies* - **Rabies** incidence is **sporadic** and does not follow predictable cyclic trends - Transmission occurs through contact with infected animals (usually dog bites) - Occurrence is unpredictable and depends on random animal exposures rather than population immunity dynamics *Incorrect Option: Cholera* - **Cholera** may show **seasonal variation** (related to rainfall and temperature) but does not exhibit the characteristic **multi-year cyclic patterns** seen in measles - Incidence is primarily driven by **environmental factors** such as water contamination, sanitation, and hygiene rather than accumulation of susceptibles - Outbreaks are more episodic and linked to specific environmental conditions *Incorrect Option: Hepatitis B* - **Hepatitis B** is a **chronic endemic infection** that does not demonstrate cyclic trends in incidence - Prevalence is influenced by **persistent transmission**, vaccination programs, and practices related to blood/body fluid exposure - Shows stable endemic patterns rather than periodic epidemic cycles

Question 1819: In epidemiology, generation time is defined as:

A. The interval of time between the receipt of infection by host and maximal infectivity of the host. (Correct Answer)
B. The interval of time between the receipt of infection by host and the appearance of first sign or symptom of the disease.
C. The interval between the receipt of infection and the onset of symptoms.
D. The interval of time between successive cases in a chain of transmission.

Explanation: ***The interval of time between the receipt of infection by host and maximal infectivity of the host*** - This definition accurately describes **generation time**, which measures the period from infection of an individual to their maximum infectiousness for transmitting the pathogen to others. - It is distinct from the incubation period as it focuses on the **infectious potential** rather than symptom onset. *The interval of time between the receipt of infection by host and the appearance of first sign or symptom of the disease.* - This definition describes the **incubation period**, which measures the time from infection to the initial manifestation of symptoms. - While related to disease progression, it does not directly reflect the timing of **maximal infectivity**. *The interval between the receipt of infection and the onset of symptoms.* - This is another way of defining the **incubation period**, focusing on the host's symptomatic response rather than their ability to transmit the infection. - It does not capture the **transmission dynamics** inherent in the concept of generation time. *The interval of time between successive cases in a chain of transmission* - This definition pertains to the **serial interval**, which measures the time between symptom onset in an infected individual and symptom onset in individuals they infect. - While important for understanding transmission chains, it differs from **generation time** by focusing on symptom onset rather than maximal infectivity.

Question 1820: Demographic gap refers to:

A. Disparity in the population size of males and females
B. Disparity between the number of births and deaths in a population (Correct Answer)
C. Disparity in age-specific birth and death rates
D. Disparity in life expectancy between males and females

Explanation: ***Disparity between the number of births and deaths in a population*** - The **demographic gap** specifically refers to the difference between the **birth rate** and the **death rate** in a given population. - A large demographic gap, where birth rates exceed death rates significantly, leads to **population growth**. - This concept is fundamental to understanding **demographic transition** and population dynamics. *Disparity in the population size of males and females* - This describes **sex ratio imbalance** or **gender gap**, not the demographic gap. - It refers to the number of males per 100 females or vice versa. *Disparity in age-specific birth and death rates* - While age-specific rates are components of demographic analysis, the concept of a "demographic gap" focuses on the *overall* difference between total births and deaths. - This is a more granular aspect of demographic analysis rather than the broad definition of the demographic gap. *Disparity in life expectancy between males and females* - This is known as the **gender gap in life expectancy** and is a measure of health and social inequality. - It does not directly represent the difference between birth rates and death rates in a population.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free